School of Pharmacy and Pharmaceutical Sciences 2019-20 Annual Report

SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES

2019-2020 ANNUAL REPORT

2019-2020 ANNUAL REPORT

SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES Binghamton University’s School of Pharmacy and Pharmaceutical Sciences is a research-intensive school on the leading edge of pharmacy education, providing students with opportunities to work directly with faculty in drug discovery, cancer, Lyme disease, opioid use syndrome, muscular dystrophy and patientoriented clinical research. At the same time, our students can choose to follow The Rural and Underserved Service Track (TRUST) that prepares them to serve rural, underserved populations through interprofessional teamwork.

Our school’s research continues to expand as we bring on faculty and garner federal and private industry funding, and our partnerships with hospitals and healthcare facilities have expanded to allow us to realize a Clinical Education Center on the Northwell Health campus, providing our students yet another opportunity to access expertise and hone their pharmacy skills.

With sound educational, clinical and research experiences gained during their time at Binghamton, our students are being prepared to practice at the top of their license no matter what career path they choose.

This 2019-2020 annual report is a comprehensive account of the achievements of our faculty — including their research presentations, publications and funding — in a year that was curtailed due to the COVID-19 pandemic.

Our presentations

Marissa Barbieri, Clinical Coordinator Platform Presentation: Barbieri M. “Experience with Acute and Chronic Lyme Subject Sample Collections for Biomarker Studies at SOPPS.” SUNY Lyme Working Group Research Conference, Binghamton University School of Pharmacy and Pharmaceutical Sciences. Johnson City, N.Y.

Aaron Beedle, PhD Poster Presentation: Beedle AM. “Muscle regeneration profile after injury in fukutindeficient dystroglycanopathy muscular dystrophy.” Gordon Research Conference on Myogenesis. Il Ciocco, Italy.

Session Chair and Panelist: MDA Scholars Session, Muscular Dystrophy Association Clinical and Scientific Conference. Conference canceled due to COVID-19.

KarenBeth Bohan, PharmD

Utkarsh Dang, PhD

Poster Presentation: Bohan KH, Nambatya W, Eneh P and Nicol MR. “Phenytoin dosing practices in traumatic brain injury in the absence of therapeutic drug monitoring availability in Uganda.”

American College of Clinical Pharmacy.

New York, N.Y.

Platform Presentation: Dang UJ, Gallaugher MPB, Browne RP and McNicholas PD. “Model-based clustering using mixtures of multivariate skewed power exponential distributions.” American Mathematical Society Fall. Binghamton, N.Y.

Poster Presentation: Kufel WD, Snyder J, Lubowski TJ, McKenna VA, Jester J and Bohan KH. “Impact of Pharmacist-Led Antimicrobial Stewardship Educational Initiatives on Antibiotic Prescriptions and Duration in Rural Outpatient Clinics.”

American College of Clinical Pharmacy.

New York, N.Y.

Poster Presentation: Dang UJ, Ziemba M, Barbieri M, Roy R, Thapa K, Russell A, Barthel B and Hoffman EP. “Molecular markers of clinical severity in Becker muscular dystrophy.” Muscular Dystrophy Association.

Abstract Accepted: Presentation canceled due to COVID-19.

Anthony Di Pasqua, PhD

Poster Presentation: Cosler L. “Opioid Restrictions by State.” Academy of Managed Care Pharmacy. Abstract accepted: Presentation canceled due to COVID-19.

Poster Presentation: Sun M, Shi Y and Di Pasqua AJ. “Enhanced efficacy of optimized phenethyl isothiocyanate and cisplatin coencapsulated liposome nanoparticle for treatment of non-small cell lung cancer.”

American Association for Cancer Research.

Atlanta, Ga.

Poster Presentation: Sabounchi S, Atav S, Cosler L, Kianmehr H, Sabounchi N. “Using Machine Language to Investigate Factors Predicting Dental Opioid Prescribing Patterns in Emergency Departments.”

AcademyHealth. Washington, D.C.

Poster Presentation: Flint BN, Osipitan OO, Sun M and Di Pasqua AJ. “Development of a lidocaine carbomer gel for application during medical procedures.” Winner: Top Poster prize. Pharmacists Society of the State of New York. Albany, N.Y.

Leon Cosler, PhD

Poster Presentation: Patel J, Volino L, Barone J, Cosler L, Kane-Gill S, Wang E, Toscani M. “Opioid Abuse Risk Among Pharmacy Students.” International Conference on Opioids, Harvard Medical School. Boston, Mass.

Bennett Doughty, PharmD Platform Presentation: Caylor M, Chudow M, Doughty B, Fusco N, Hayes S, Lichvar A and McCreary E. “Late Breaking Literature and Recent Developments in Clinical Pharmacy

Practice.” Continuing Education, 1.5 credit hours; American College of Clinical Pharmacy.

New York, N.Y.

DMD biomarkers.” Research in Pediatric Developmental Pharmacology U54 Meeting.

Bethesda, Md.

“Marijuana Use and Toxicities.” Pharmacists Society of the State of New York.

Tarrytown, N.Y.

Platform Presentation: Doughty B. “Updates in Guthrie’s Alcohol Withdrawal Protocol.”

Robert Packer Hospital Administration and Education Meeting. Sayre, Pa.

Platform Presentation: Edwards K. “Selective detection of thiamine in complex biological matrices using bacteria-derived binding proteins.” International Association for Great Lakes Research. Brockport, N.Y.

Platform Presentation: Eggleston W. “Emerging Drug Trends.” United Health Services Grand Rounds. Binghamton, N.Y.

Platform Presentation: Doughty B. “The Rural and Underserved Service Track.” Binghamton University Decker School of Nursing and Department of Social Work, in tandem with Care Compass. Binghamton, N.Y.

Poster Presentation: Ernst E, Stahura C and Edwards K. “Development of Assay Platforms for Monitoring Human C-Reactive Protein.”

Binghamton University Research Days.

Binghamton, N.Y. Poster Presentation: Macri A, Harris R and Edwards K. “Maximizing the Efficiency of Prednisolone in Duchenne Muscular Dystrophy through Reformulation.”

Binghamton University Research Days.

Binghamton, N.Y.

William Eggleston, PharmD Platform Presentation: Eggleston W. “Kratom: Friend or Foe.” North American Congress of Clinical Toxicology. Nashville, Tenn.

Katie Edwards, PhD Platform Presentation: Edwards K. “Selective detection of non-immunogenic targets using periplasmic binding proteins.” Loyola University. New Orleans, La. Platform Presentation: Edwards K. “Engineering point-of-care assays for

Platform Presentation: Eggleston W. “Naloxone: Closing the Access Gap.” North American Congress of Clinical Toxicology.

Nashville, Tenn.

Platform Presentation: Eggleston W. “Irritant Gases.” North American Congress of Clinical Toxicology. Nashville, Tenn.

Platform Presentation: Eggleston W. “Local Efforts to Reduce Overdose Deaths.” Broome Opioid Awareness Council. Binghamton, N.Y. Platform Presentation: Eggleston W.

Yetrib Hathout, PhD Poster Presentation: Smith H, Alayi TD, Barbieri M, Goswami MV, Roy R, Thapa K and Hathout Y. “Screening for Borrelia burgdorferi proteins in ticks and patients with Lyme disease using Mass Spectrometry Proteomic Approach.” Undergraduate Chemistry Research, Binghamton University.

Binghamton, N.Y. Platform presentation: Hathout Y. “Biomarker Development for Lyme Disease.”

SUNY Lyme Working Group Research Conference, Binghamton University School of Pharmacy and Pharmaceutical Sciences.

Johnson City, N.Y. Poster Presentation: Tawalbeh SM, Alayi TD, Canessa EH, Goswami MV and Hathout Y. “Examining the effect of deflazacort & prednisolone on skeletal muscle using cultured human myotubes & SILAC strategy.”

American Society for Mass Spectrometry.

Virtual.

Poster Presentation: Ogundele M, Alayi T, Goswami MV, Canessa E, Tawalbeh SM, Barbieri M and Hathout Y. “The clinical relevance of Gelsolin in Duchenne Muscular Dystrophy.” Muscular Dystrophy Association.

Orlando, Fla. Abstract Accepted: Presentation canceled due to COVID-19.

Eric Hoffman, PhD Platform Presentation: Hoffman E. “Therapies and outcome measures for muscular dystrophy.” Science of Ability Symposium, Shirley Ryan AbilityLab. Chicago, Ill. Platform Presentation. Hoffman E. “Vamorolone 18-month treatment in Duchenne muscular dystrophy.” World Muscle Society. Copenhagen, Denmark.

Wesley Kufel, PharmD Poster Presentation: Cho JC, Kufel WD, Jeffres MN and Chahine E. “Characterization of Infectious Diseases Advanced Pharmacy Practice Experiences at United States Colleges of Pharmacy.” IDWeek. Washington, D.C. Poster Presentation: Shakeraneh P, Gilotra T, Wang D, Fazili T, Steele JM, Seabury RW, Miller CD and Kufel WD. “Comparison of Vancomycin Continuous and Intermittent Infusion Dosing Strategies Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.” IDWeek. Washington, D.C. Platform Presentation: Kufel WD, Staicu ML and Avery LM. “Penicillin Allergy? Maybe Not.” Continuing Education, 2 credit hours; Central New York Society of Health-System Pharmacists. Syracuse, N.Y. Radio Presentation/Interview: Kufel WD. “Update on COVID-19: Novel Coronavirus.” WNBF News Radio (Townsquare Media, Inc). Binghamton, N.Y. Platform Presentation: Kufel WD. “Clinical Pearls for Students – Infectious Diseases.”

American Society of Health-System Pharmacists. Las Vegas, Nev.

Platform Presentation: Kufel WD. “Section of Clinical Specialists and Scientists Infectious Diseases Network Facilitator Session.” American Society of Health-System Pharmacists. Las Vegas, Nev.

Moderator: Annual Patient Conference, The Myositis Association. Minneapolis, Minn.

Platform Presentation: Nagaraju K. “Inflammation and immune response.”

Muscular Dystrophy Association. Orlando, Fla.

Platform Presentation: Kufel WD, Steele JM. “The Times Are Changing – Implementation of Vancomycin AUC-Based Monitoring.” Continuing Education, 1 credit hour; New York State American College of Clinical Pharmacy. Scotia, N.Y.

Melissa Morales, PhD Platform Presentation: Morales M. “Oh, The Places You’ll Go! (Science Edition).”

Undergraduate Research Science Symposium, SUNY Cortland. Cortland N.Y.

Kanneboyina Nagaraju, DVM, PhD Platform Presentation: Nagaraju K. “Preclinical trial design and biomarker development.” Muscular Dystrophy Association. Orlando, Fla. Platform Presentation: Nagaraju K. “Autoimmune Response in Chronic Lyme Disease.” SUNY Lyme Working Group Research Conference, Binghamton University School of Pharmacy and Pharmaceutical Sciences. Johnson City, N.Y. Platform Presentation: Nagaraju K. “TreatNMD Advisory Committee for Therapeutics (TACT): a ten-year experience of an exporting model for de-risking the development of orphan drug and advanced therapies in rare disorder.” 39° Congresso Nazionale della Società Italiana di Farmacologia. Firenze, Italy.

Platform Presentation: Nagaraju K. “Duchenne and Immune system.” Solid Biosciences. Boston, Mass.

Platform Presentation: Nagaraju K. “Autoantibodies in chronic lyme disease.”

International Lyme and Associated Disease Society. Madrid, Spain.

Platform Presentation: Nagaraju K. “Drug development for myositis.” Cure Juvenile Myositis. Chicago, Ill. Platform Presentation: Nagaraju K. “Immunopathogenesis of myositis.”

Johns Hopkins University Medical School.

Baltimore, Md.

Emily Leppien, PharmD Platform Presentation: Leppien E. “Neuropsychiatric Adverse Effects of Commonly Prescribed Antibiotics.”

Continuing Education, 1 credit hour; UHS Wilson Medical Center. Johnson City, N.Y.

Poster Presentation: Kufel WD, Leppien E, Seabury RW and Lynch S. “Pharmacy Students’ Perceptions and Confidence to Recommend Appropriate Empiric Antibiotic Therapy in Infective Endocarditis Following Mannequin-Based Simulation.” IDWeek.

Washington, D.C. Poster Presentation: Wahler RG, MaertenRivera JL, Slazak EM, Lynch S, Woodruff A and Desai KJ. “Pharmacy Student Attitudes Toward Developing Curriculum for a MicroCredential in the Pharmacist’s Patient Care Process.” American Association of Colleges of Pharmacy. Chicago, Ill. Radio Presentation/Interview: Lynch S. “Ask a Pharmacist: Cough, Cold and Flu.” WNBF News Radio (Townsquare Media, Inc).

Binghamton, N.Y.

Platform Presentation: Leppien E. “Principles of Psychopharmacology.”

Continuing Education, 1 credit hour; Our Lady of Lourdes Memorial Hospital.

Binghamton, N.Y.

Sarah Lynch, PharmD Poster Presentation: Stewart-Lynch A, Lynch S, Griffin B and Vest K. “Student Confidence in Applying the PPCP to Patients Seeking Contraception: Results from Two Schools of Pharmacy.” American Association of Colleges of Pharmacy. Chicago, Ill.

Poster Presentation: Stewart-Lynch A, Lynch S, Griffin B and Vest K. “Effect of a Simulated Activity on Student Pharmacist Readiness, Ability to Use, and Confidence in Applying the PPCP to Contraceptive Prescribing.”

Winner: APhA-APPM Presentation Merit Award. American Pharmacists Association.

Virtual.

Poster Presentation: Laughlin L, Mayer D and Lynch S. “What’s the Word? Defining Community Pharmacy Interventions.”

American Pharmacists Association. Virtual.

Platform Presentation: Stewart-Lynch A and Lynch S. “Broaching Birth Control: A Pharmacist’s Perspective.” Continuing Education, 2 credit hours; American Pharmacists Association. Virtual.

Erin Pauling, PharmD Platform Presentation: Pauling EE. “Over Reflecting? (Reflection Fatigue).” American Associations of Colleges of Pharmacy.

Chicago, Ill. Radio Presentation/Interview: Pauling EE. “Ask a Pharmacist: Proper Use of Acetaminophen.” WNBF News Radio (Townsquare Media, Inc). Binghamton, N.Y.

Gail Rattinger, PharmD, PhD Poster Presentation: Pauling EE, Lynch S, Dang UJ, Mielczarek MJ, Meredith GE and Rattinger GB. “Leading Change to Instill Lifelong Learning.” American Association of Colleges of Pharmacy. Chicago, Ill. Poster Presentation: Kauzor K, Schwartz S, Tubbs Z, Hammond A, Rattinger GB and Tschanz JT. “Patterns of neuropsychiatric symptoms and survival among older adults with various subtypes of dementia. The Cache County Dementia Progression Study.”

Alzheimer’s Association. Los Angeles, Calif.

Poster Presentation: Vernon E, Rattinger GB, DeBerard MS, Kugler J and Tschanz JT. “Sex Differences in the Association between Sleep Medications and Risk of Alzheimer’s Disease: The Cache County Study (USA).” Alzheimer’s Association. Los Angeles, Calif.

Poster Presentation: Hammond AH, Vernon EK, Rattinger GB, Kauzor K and Tschanz JT. “Baseline Cognitive Status of Two Classifications of MCI and Conversion to Alzheimer’s Disease: The Cache County Memory Study.” International Neuropsychological Society. Denver, Colo.

Sara Spencer, PharmD Platform Presentation: Spencer SA. “Introduction to Medical Marijuana and Mental Health.” College of Psychiatric and Neurologic Pharmacists, Binghamton Chapter. Johnson City, N.Y. Radio Presentation/Interview: Spencer SA. “Ask a Pharmacist: Day in the life of a pharmacist.” WNBF News Radio (Townsquare Media, Inc). Binghamton, N.Y.

assay for the identification of improved ADC linkers.” American Chemical Society.

Philadelphia, Pa. Poster Presentation: Tumey LN. “Evaluation of a FRET-based peptide-library aimed at the identification of improved proteolytic substrates for cleavable linkers.” American Chemical Society. Philadelphia, Pa.

Sarah Spinler, PharmD

L. Nathan Tumey, PhD Poster Presentation: Tumey LN. “α-Effect nucleophiles as noncanonical substrates for microbial transglutaminase.” American Chemical Society. Philadelphia, Pa. Poster Presentation: Tumey LN. “Design and optimization of a turn-on fluorescence

Platform Presentation: Wilsey HA and Pandya K. “Comparison of low versus highdose four-factor prothrombin complex concentrate (4F-PCC) for factor Xa inhibitor-associated bleeding.” Society of Critical Care Medicine Congress, Research Snapshot Theater. Orlando, Fla. Radio Presentation/Interview: Wilsey HA. “Ask a Pharmacist: Go Red for Women: Heart Disease Awareness” WNBF News Radio. (Townsquare Media, Inc).

Binghamton, N.Y.

Poster Presentation: Ojo V, Barbieri M and Spencer SA. “Preliminary Analysis of SelfReported Survey Data on Lyme Disease.”

LSAMP/STEER Summer Research Preview Day, Binghamton University. Binghamton, N.Y.

Platform Presentation: Gluckman TJ, Deitelzweig SB, Fanikos J and Spinler SA. “Optimizing Outcomes When Using DOAC Reversal Agents Through Institutional Guidelines and Anticoagulation Stewardship.”

Continuing Education, 1.5 credit hours; American Journal of Managed Care Health System Forum, Pharmacy Times Continuing EducationTM. Online.

H Wilsey, PharmD

Poster Presentation: Tumey LN. “Optimizing conditions for the conjugation of unusual substrates to IgG1 antibodies using microbial transglutaminase.” American Chemical Society. Philadelphia, Pa. Poster Presentation: Tumey LN. “Bioconjugation via zwitterionic boronnitrogen heterocycles.” American Chemical Society. Philadelphia, Pa. Poster Presentation: Tumey LN. “Optimization of ADC linkers: Design and evaluation of a FRET-based ADC linkerlibrary.” American Chemical Society.

Philadelphia, Pa.

Our publications Balk EM, Adam GP, Corsi K, Mogul A, Trikalinos TA, Jeppson PC. Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review. J Gen Intern Med. 2019 Aug;34(8):1615-1625. doi: 10.1007/s11606-01905028-0. Epub 2019 May 6. PMID: 31062225; PMCID: PMC6667523.

Beccari MV, Seabury RW, Mogle BT, Kufel WD, Miller CD, Steele JM. Cost comparison of AUC:MIC- versus troughbased vancomycin monitoring for MRSA bacteremia. J Am Pharm Assoc (2003). 2020 Mar 26:S1544-3191(20)30105-9. doi: 10.1016/j. japh.2020.02.025. Epub ahead of print. PMID: 32224054.

Bello L, D’Angelo G, Villa M, Fusto A, Vianello S, Merlo B, Sabbatini D, Barp A, Gandossini S, Magri F, Comi GP, Pedemonte M, Tacchetti P, Lanzillotta V, Trucco F, D’Amico A, Bertini E, Astrea G, Politano L, Masson R, Baranello G, Albamonte E, De Mattia E, Rao F, Sansone VA, Previtali S, Messina S, Vita GL, Berardinelli A, Mongini T, Pini A, Pane M, Mercuri E, Vianello A, Bruno C, Hoffman EP, Morgenroth L, Gordish-Dressman H, McDonald CM; CINRG-DNHS Investigators, Pegoraro E. Genetic modifiers of respiratory function in Duchenne muscular dystrophy. Ann Clin Transl Neurol. 2020 May;7(5):786-798. doi: 10.1002/acn3.51046. Epub 2020 Apr 28. PMID: 32343055; PMCID: PMC7261745.

Bhavsar-Jog YP, Van Dornshuld E, Brooks TA, Tschumper GS, Wadkins RM. Co-Localization of DNA i-Motif-Forming Sequences and 5-Hydroxymethyl-cytosines in Human

Embryonic Stem Cells. Molecules. 2019 Oct 8;24(19):3619. doi: 10.3390/molecules24193619.

PMID: 31597270; PMCID: PMC6804057.

Bohan KH, Flores EK, Rajab K, Nambatya W, Nicol MR, Crowe SJ, Manning DH, Eneh P, Adome RO. Improving pharmaceutical care education in Uganda through sustainable experiential programs and research. J Am Coll Clin Pharm. 2020;1– 12. doi: https://doi. org/10.1002/jac5.1255. Epub 2020 May 5.

Butler L, Chen AMH, Borja-Hart N, Arif S, Armbruster AL, Petry N, Riley AC. Assessment of a multi-institution integration of cultural competency activities. Curr Pharm Teach Learn. 2020 May;12(5):517-523. doi: 10.1016/j. cptl.2020.01.007. Epub 2020 Jan 31. PMID: 32336447.

Chehovich C, Demler TL, Leppien E, Trigoboff E. The role of serum lithium concentration on pill burden for psychiatric populations. Innov Clin Neurosci. 2020;17(4–6):18–22. Epub 2020 Apr 1.

Cheng JWM, Colucci V, Kalus JS, Spinler SA. Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease. Ann Pharmacother.

2020 Jun 13:1060028020934001. doi: 10.1177/1060028020934001. Epub ahead of print. PMID: 32536199.

Cheng JWM, Colucci V, Kalus JS, Spinler SA. Reply: Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent? Ann Pharmacother. 2019 Oct;53(10):1072. doi: 10.1177/1060028019862262.

Epub 2019 Jul 4. PMID: 31271040.

Canessa EH, Goswami MV, Alayi TD, Hoffman EP, Hathout Y. Absolute quantification of dystrophin protein in human muscle biopsies using parallel reaction monitoring (PRM). J Mass Spectrom. 2020 Feb;55(2):e4437. doi: 10.1002/jms.4437. Epub 2019 Nov 8. PMID: 31502334.

Chio TI, Demestichas BR, Brems BM, Bane SL, Tumey LN. Expanding the Versatility of Microbial Transglutaminase Using α-Effect Nucleophiles as Noncanonical Substrates.

Angew Chem Int Ed Engl. 2020 Apr 8. doi: 10.1002/anie.202001830. Epub ahead of print.

PMID: 32268004.

Casavant J, Ratnayake AS, Puthenveetil S, Tumey LN. Detection and Removal of Small Molecule and Endotoxin Contaminants in ADC Preparations. Methods Mol Biol.

2020;2078:291-299. doi: 10.1007/978-1-49399929-3_20. PMID: 31643065.

Cho JC, Crotty MP, Kufel WD, Chahine EB, Sofjan AK, Gallagher JC, Estrada SJ. Learning Experiences Within Infectious Diseases Pharmacy Residency Programs in the United States: A Cross-Sectional Survey. Open Forum Infect Dis. 2019 Sep 6;6(10):ofz387. doi: 10.1093/ofid/ofz387. PMID: 31660350; PMCID: PMC6790394.

Chehovich C, Demler TL, Leppien E. Impact of Ramadan fasting on medical and psychiatric health. Int Clin Psychopharmacol.

2019 Nov;34(6):317-322. doi: 10.1097/ YIC.0000000000000275. PMID: 31274697.

Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, Smith EC, McDonald CM, Zaidman CM, Morgenroth LP, Osaki H, Satou Y, Yamashita

T, Hoffman EP; CINRG DNHS Investigators.

Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2020 May 26. doi: 10.1001/jamaneurol.2020.1264.

Epub ahead of print. PMID: 32453377.

Conklin LS, Hoffman EP, van den Anker J. Developmental Pharmacodynamics and Modeling in Pediatric Drug Development. J Clin Pharmacol. 2019 Sep;59 Suppl 1(Suppl 1):S87-S94. doi: 10.1002/jcph.1482. PMID: 31502687; PMCID: PMC6741426.

Damsker JM, Cornish MR, Kanneboyina P, Kanneboyina I, Yu Q, Lipson R, Phadke A, Knoblach SM, Panchapakesan K, Morales M, Fiorillo AA, Partridge T, Nagaraju K. Vamorolone, a dissociative steroidal compound, reduces collagen antibodyinduced joint damage and inflammation when administered after disease onset. Inflamm Res. 2019 Nov;68(11):969-980. doi: 10.1007/ s00011-019-01279-z. Epub 2019 Aug 24. PMID: 31446438; PMCID: PMC6814568.

Dang UJ, Ziemba M, Clemens PR, Hathout Y, Conklin LS, CINRG Vamorolone 002/003 Investigators, Hoffman EP. Serum biomarkers associated with baseline clinical severity in young steroid-naive Duchenne muscular dystrophy boys. Hum Mol Genet.

2020 Aug 1;29(15): 2481-2495. doi: https:// doi.org/10.1093/hmg/ddaa132. Epub 2020 June 27.

Doughty B, Morgenson D, Brooks T. Lofexidine: A Newly FDA-Approved,

Nonopioid Treatment for Opioid Withdrawal.

Ann Pharmacother. 2019 Jul;53(7):746-753. doi: 10.1177/1060028019828954. Epub 2019 Feb 6. PMID: 30724094.

Doughty B, Tumey LN, Williams K. Case report: Albendazole associated psychosis.

Ment Health Clin. 2019 Nov 27;9(6):397-400. doi: 10.9740/mhc.2019.11.397. PMID: 31857936; PMCID: PMC6881107.

Edwards KA, Randall EA, Tu-Maung N, Sannino DR, Feder S, Angert ER, Kraft CE. Periplasmic binding protein-based magnetic isolation and detection of thiamine in complex biological matrices. Talanta.

2019 Dec 1;205:120168. doi: 10.1016/j. talanta.2019.120168. Epub 2019 Jul 22. PMID: 31450459.

Eggleston W, Calleo V, Kim M, Wojcik S. Naloxone Administration by Untrained Community Members. Pharmacotherapy.

2020 Jan;40(1):84-88. doi: 10.1002/phar.2352.

Epub 2019 Dec 17. PMID: 31782193.

Eggleston W, Palmer R, DubĂŠ PA, Thornton S, Stolbach A, Calello DP, Marraffa JM. Loperamide toxicity: recommendations for patient monitoring and management. Clin Toxicol (Phila). 2020 May;58(5):355-359. doi: 10.1080/15563650.2019.1681443. Epub 2019 Nov 4. PMID: 31684751.

Farooq S, Felix K, Spencer SA. Considerations for Older Patients With Diabetes in LongTerm Care Settings. Sr Care Pharm. 2020 Mar 1;35(3):120-125. doi: 10.4140/TCP.n.2020.120.

PMID: 32070460.

Gois Beghini D, Iwao Horita S, Monteiro da Fonseca Cardoso L, Anastacio Alves L, Nagaraju K, Henriques-Pons A. A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies-In Vitro and In Vivo Treatments to Boost Cellular Engraftment.

Int J Mol Sci. 2019 Oct 31;20(21):5433. doi: 10.3390/ijms20215433. PMID: 31683627; PMCID: PMC6861917.

Hall PD, Fish H, McBane S, Mercer J, Moreau C, Owen J, Policastri A, Rattinger GB, Srivastava SB, Thomas MC, Bradley-Baker LR. The Report of the 2018-2019 Professional Affairs Standing Committee: The Role of Educators in Pharmacy Practice Transformation. Am J Pharm Educ. 2019 Dec;83(10):7596. doi: 10.5688/ajpe7596. PMID: 32001892; PMCID: PMC6983901.

Hathout Y, Liang C, Ogundele M, Xu G, Tawalbeh SM, Dang UJ, Hoffman EP, GordishDressman H, Conklin LS, van den Anker JN, Clemens PR, Mah JK, Henricson E, McDonald C. Disease-specific and glucocorticoidresponsive serum biomarkers for Duchenne Muscular Dystrophy. Sci Rep. 2019 Aug 21;9(1):12167. doi: 10.1038/s41598-019-48548-9.

PMID: 31434957; PMCID: PMC6704115.

Hoffman EP, Schwartz BD, Mengle-Gaw LJ, Smith EC, Castro D, Mah JK, McDonald CM, Kuntz NL, Finkel RS, Guglieri M, Bushby K, Tulinius M, Nevo Y, Ryan MM, Webster R, Smith AL, Morgenroth LP, Arrieta A, Shimony M, Siener C, Jaros M, Shale P, McCall JM, Nagaraju K, van den Anker J, Conklin LS, Cnaan A, Gordish-Dressman H, Damsker JM, Clemens PR; Cooperative International Neuromuscular

Research Group. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function. Neurology.

2019 Sep 24;93(13):e1312-e1323. doi: 10.1212/ WNL.0000000000008168. Epub 2019 Aug 26. PMID: 31451516; PMCID: PMC7011869.

Hoffman EP. Pharmacotherapy of Duchenne Muscular Dystrophy. Handb Exp Pharmacol.

2019 Aug 3. doi: 10.1007/164_2019_256. Epub ahead of print. PMID: 31375923.

Jeffres MN, Kufel WD, Biehle LR, Cho JC, Narayanan N, Gruenberg K, Garcia J, MacDougall C. A Comprehensive Survey of Infectious Diseases Curriculum Among US Pharmacy Schools. Am J Pharm Educ. 2019 Nov;83(9):7168. doi: 10.5688/ajpe7168. PMID: 31871346; PMCID: PMC6920648.

10.1002/art.41215. Epub ahead of print. PMID: 32009304.

3;21:e00863. doi: 10.1016/j.idcr.2020.e00863.

PMID: 32577400; PMCID: PMC7300106.

Kooner M, Joseph H, Griffin B, Lynch S, Vest K, Stewart-Lynch A, Weaver K. Hormonal Contraception Prescribing by Pharmacists: 2019 Update. J Am Pharm Assoc. doi: https:// doi.org/10.1016/j.japh.2020.01.015. Epub 2020 Jan.

Li X, Conklin LS, van den Anker J, Hoffman EP, Clemens PR, Jusko WJ. ExposureResponse Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy. J Clin Pharmacol. 2020 May 20. doi: 10.1002/ jcph.1632. Epub ahead of print. PMID: 32434278.

Kufel WD, Armistead PM, Daniels LM, Ptachcinski JR, Alexander MD, Shaw JR. Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary? J Pharm Pract. 2020 Apr;33(2):226-230. doi: 10.1177/0897190018790688. Epub 2018 Jul 26.

PMID: 30049245.

Justo JA, Kufel WD, Avery L, Bookstaver PB. Penicillin Allergy Skin Testing in the Inpatient Setting. Pharmacy (Basel). 2019 Aug 27;7(3):120. doi: 10.3390/pharmacy7030120.

PMID: 31461837; PMCID: PMC6789445.

Kufel WD, Justo JA, Bookstaver PB, Avery LM. Penicillin Allergy Assessment and Skin Testing in the Outpatient Setting. Pharmacy (Basel). 2019 Sep 19;7(3):136. doi: 10.3390/ pharmacy7030136. PMID: 31546887; PMCID: PMC6789533.

Kelley EF, Cross TJ, Snyder EM, McDonald CM; CINRG Investigators, Hoffman EP, Bello L. Influence of β2 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy. Respir Res. 2019 Oct 16;20(1):221. doi: 10.1186/s12931-0191200-1. PMID: 31619245; PMCID: PMC6796481.

Kufel WD, Mastro KA, Mogle BT, Williams KS, Jester J, Snyder J, Lubowski T, Bohan KH. Providers’ knowledge and perceptions regarding antibiotic stewardship and antibiotic prescribing in rural primary care clinics. J Am Coll Clin Pharm. 2020 Dec 10;3:601-608. doi: 10.1002/jac5.1198

Kinder TB, Heier CR, Tully CB, Van der Muelen JH, Hoffman EP, Nagaraju K, Fiorillo AA. Muscle weakness in myositis: microRNAs mediate dystrophin reduction in MHC class I transgenic mouse model and human muscle biopsies. Arthritis Rheumatol. 2020 Feb 3. doi:

Kufel WD, Steele JM, Riddell SW, Jones Z, Shakeraneh P, Endy TP. Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations. IDCases. 2020 Jun

López SM, Balog-Alvarez C, Canessa EH, Hathout Y, Brown KJ, Vitha S, Bettis AK, Boehler J, Kornegay JN, Nghiem PP. Creation and characterization of an immortalized canine myoblast cell line: Myok9. Mamm Genome. 2020 Apr;31(3-4):95-109. doi: 10.1007/s00335-020-09833-5. Epub 2020 Apr 3. PMID: 32246189.

Macartney-Coxson D, Danielson K, Clapham J, Benton MC, Johnston A, Jones A, Shaw O, Hagan RD, Hoffman EP, Hayes M, Harper J, Langston MA, Stubbs RS. MicroRNA Profiling in Adipose Before and After Weight Loss Highlights the Role of miR-223-3p and the NLRP3 Inflammasome. Obesity (Silver Spring). 2020 Mar;28(3):570-580. doi: 10.1002/oby.22722. PMID: 32090515; PMCID: PMC7046053.

Matyi JM, Rattinger GB, Schwartz S, Buhusi M, Tschanz JT. Lifetime estrogen exposure and cognition in late life: the Cache County Study.

Menopause. 2019 Dec;26(12):1366-1374. doi: 10.1097/GME.0000000000001405. PMID: 31613825.

Mayer D, Lynch S. Bremelanotide: New Drug Approved for Treating Hypoactive

Sexual Desire Disorder. Ann Pharmacother.

2020 Jan 1:1060028019899152. doi: 10.1177/1060028019899152. Epub ahead of print. PMID: 31893927.

Mogul A, Corsi K, McAuliffe L. Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis. Ann Pharmacother. 2019 Sep;53(9):947-953. doi: 10.1177/1060028019839650. Epub 2019 Mar 24. PMID: 30907116.

Mogul A, Laughlin E, Lynch S. Sharks Off the CAPE: Using a ‘Shark Tank’ Style Co-Curricular to Introduce Innovation and Entrepreneurship.

Am J Pharm Educ. 2020 Aug;84(8): ajpe7805. doi: https://doi.org/10.5688/ajpe7805. Epub 2020 Mar 18.

Mogul A, Teixeira E, McAuliffe L, Promrat K, Zullo AR. Effectiveness of crushed sofosbuvirvelpatasvir in a patient with dysphagia. Am J Health Syst Pharm. 2020 Mar 5;77(6):417-418. doi: 10.1093/ajhp/zxz326. PMID: 31930300.

Morgan RK, Psaras AM, Lassiter Q, Raymer K, Brooks TA. G-quadruplex deconvolution with physiological mimicry enhances primary screening: Optimizing the FRET Melt2 assay.

Biochim Biophys Acta Gene Regul Mech.

2020 Jan;1863(1):194478. doi: 10.1016/j. bbagrm.2019.194478. Epub 2019 Dec 28.

PMID: 31891781.

Nuckolls GH, Kinnett K, Dayanidhi S, Domenighetti AA, Duong T, Hathout Y, Lawlor MW, Lee SSM, Magnusson SP, McDonald CM, McNally EM, Miller NF, Olwin BB, Raghavan P, Roberts TJ, Rutkove SB, Sarwark JF, Senesac CR, Vogel LF, Walter GA, Willcocks

RJ, Rymer WZ, Lieber RL. Conference report on contractures in musculoskeletal and neurological conditions. Muscle Nerve. 2020 Jun;61(6):740-744. doi: 10.1002/mus.26845.

Epub 2020 Mar 7. PMID: 32108365; PMCID: PMC7229996.

Sanders CL, Rattinger GB, DeBerard MS, Hammond AG, Wengreen H, Kauwe JSK, Buhusi M, Tschanz JT. Interaction between Physical Activity and Genes Related to Neurotrophin Signaling in Late-Life Cognitive Performance: The Cache County Study.

J Gerontol A Biol Sci Med Sci. 2019 Sep 6:glz200. doi: 10.1093/gerona/glz200. Epub ahead of print. PMID: 31504225.

Seabury R, Darko W, Miller CD, Steele JM, Kufel WD. Publications for Pharmacy Residents Are Challenging but Not “Nearly Unattainable”. Hosp Pharm. 2020 Jun;55(3):153. doi: 10.1177/0018578719882316.

Epub 2019 Oct 16. PMID: 32508351; PMCID: PMC7243602.

Seyedzadeh Sabounchi S, Seyedzadeh Sabounchi S, Cosler LE, Atav AS. Opioid prescribing and misuse among dental patients in the US: a literature-based review.

Quintessence Int. 2020;51(1):64-76. doi: 10.3290/j.qi.a43697. PMID: 31813941.

Shakeraneh P, Fazili T, Wang D, Gilotra T, Steele JM, Seabury RW, Miller CD, Darko W, Probst LA, Kufel WD. Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.

Pharmacotherapy. 2020 Apr;40(4):357-362.

doi: 10.1002/phar.2381. Epub 2020 Mar 13.

PMID: 32090347.

Shakeraneh P, Robinson R, Kufel WD, Tumey LN, Benjamin SR, Miller CD, Darko W, Probst LA, Seabury, RW. Chemical and Physical Stability of an Admixture Containing Cefepime and Vancomycin in Lactated Ringer Solution. Hospital Pharmacy. 2020 Jan. doi: 10.1177/0018578719901278.

Spitali P, Zaharieva I, Bohringer S, Hiller M, Chaouch A, Roos A, Scotton C, Claustres M, Bello L, McDonald CM, Hoffman EP; CINRG Investigators, Koeks Z, Eka Suchiman H, Cirak S, Scoto M, Reza M, ‘t Hoen PAC, Niks EH, Tuffery-Giraud S, Lochmüller H, Ferlini A, Muntoni F, Aartsma-Rus A. TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy. Eur J Hum Genet. 2020 June;28(6):815-825. doi: https:// doi.org/10.1038/s41431-019-0563-6. Epub 2020 Jan 2.

Thangarajh M, Zhang A, Gill K, Ressom HW, Li Z, Varghese RS, Hoffman EP, Nagaraju K, Hathout Y, Boca SM. Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne. PLoS One. 2019 Jul 16;14(7):e0219507. doi: 10.1371/journal. pone.0219507. PMID: 31310630; PMCID: PMC6634414.

Tumey LN. An Overview of the Current ADC Discovery Landscape. Methods Mol Biol.

2020;2078:1-22. doi: 10.1007/978-1-4939-99293_1. PMID: 31643046.

Uaesoontrachoon K, Srinivassane S, Warford J, Mekhssian K, Montpetit H, Beauvois R, Keyhani A, Hathout Y, Yamashita T, Satou Y, Osaki H, Praest M, Moraca M, Malbasic M, Ross W, MacKinnon A, Rowsell J, Mullen A, Matyas M, Mummidivarpu S, Nagaraju K, Hoffman EP. Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development. Biomark Med. 2019 Oct;13(14):1209-1225. doi: 10.2217/bmm-20190242. Epub 2019 Aug 5. PMID: 31379197.

Uapinyoying P, Goecks J, Knoblach SM, Panchapakesan K, Bonnemann CG, Partridge TA, Jaiswal JK, Hoffman EP. A long-read RNAseq approach to identify novel transcripts of very large genes. Genome Res. 2020 Jun;30(6):885-897. doi: 10.1101/gr.259903.119.

Epub 2020 Jul 6. PMID: 32660935; PMCID: PMC7370890. van Breemen RB, Hathout Y, Fabris D. Catherine Fenselau: A distinguished career dedicated to biomedical mass spectrometry.

J Mass Spectrom. 2020 Feb;55(2):e4500. doi: 10.1002/jms.4500. PMID: 32073193.

Vohra V, Marraffa JM, Wojcik SM, Eggleston W. An assessment of urine THC immunoassay in healthy volunteers receiving an oral proton-pump inhibitor. Clin Toxicol (Phila). 2020 Jun;58(6):498-500. doi: 10.1080/15563650.2019.1662917. Epub 2019 Sep 30. PMID: 31566030.

Willmann R, Lee J, Turner C, Nagaraju K, Aartsma-Rus A, Wells DJ, Wagner KR, Csimma C, Straub V, Grounds MD, De Luca A. Improving translatability of preclinical

studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT). Dis Model Mech.

2020 Feb 7;13(2):dmm042903. doi: 10.1242/ dmm.042903. PMID: 32066568; PMCID: PMC7044444.

Kufel WD. Febrile Neutropenia. In: Cho JC, editor. Infectious Diseases: A Case Study Approach [Internet]. McGraw-Hill; c2020 [cited 2020 Sept 9]. Available from: https:// accesspharmacy.mhmedical.com/content. aspx?bookid=2810&sectionid=238116211.

Wilsey HA, Bailey AM, Schadler A, Davis GA, Nestor M, Pandya K. Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor-Associated Bleeding: A Retrospective Study. J Intensive Care Med. 2020 Apr 3:885066620916706. doi: 10.1177/0885066620916706. Epub ahead of print. PMID: 32242482.

Leppien L, Bystrak T, Doughty B. Antipsychotic agents. In: Ray SD, editor. Side effects of drugs annual: A worldwide yearly survey of new data in adverse drug reactions. Cambridge (MA): Elsevier; 2019. Vol 41. p. 51-63.

Wilsey HA, Burgess DR, Burgess DS. Focusing the lens on the CAMERA concepts: Early combination β-lactam and vancomycin therapy in methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2020 May 4:AAC.00360-20. doi: 10.1128/AAC.00360-20. Epub ahead of print.

PMID: 32366709.

Book Chapters Canessa E, Goswami MV, Samsel AM, Ogundele M, Tawalbeh SM, Alayi TD, Hathout Y. Proteome Profiling of Muscle Cells and Muscle Tissue Using Stable Isotope Labeling

by Amino Acids. In: Burniston J, Chen YW, editors. Omics Approaches to Understanding Muscle Biology. Methods in Physiology. New York (NY): Springer; 2019. p. 155-169.

Riley AC, Spencer SA, Wade L. Telepharmacy: building a connection to close the healthcare gap. In: Covvey JR, Arya V, DiPietro Mager N, Gilman N, Herring M, Lukas S, Ochs L, Waddington L, editors. Public health in pharmacy practice: a casebook. 1st ed.

Genesco, NY: Open SUNY Textbooks; c2020 [cited 2020 Sept 9]. Available from: https:// courses.lumenlearning.com/suny-publichealth-in-pharmacy-practice/.

Vest K, Lynch SE. Endometriosis. In: DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V, editors.

Pharmacotherapy: A Pathophysiologic Approach [Internet]. McGraw-Hill; c2020 [cited 2020 Sept 9]. Available from: https:// accesspharmacy.mhmedical.com/content. aspx?bookid=2577&sectionid=226724883.

Our funding Total research expenditures: $1,314,775

Aaron Beedle $133,865 Total expenditures

Utkarsh Dang $40,154 Total expenditures

Yetrib Hathout $611,831 Total expenditures

$78,698 Is MTOR inhibition a valid therapy for dystroglycan muscular dystrophy Muscular Dystrophy Association of America

$27,409 Defining Serum Biomarkers of Early-Age Severity for Duchenne muscular dystrophy - Statistical Research Using Vamorolone 002 Data Foundation to Eradicate Duchenne

$93,079 Generating the Evidentiary Data Package for Dystrophin Biomarker Qualifications U.S. Army Medical Research Acquisition Activity

$40,265 Structure and Function in AlphaDystroglycan Glycosylation University of Georgia (subcontract) $14,902 SBIR Phasel: Building an Evidentiary Case for Circulating GHBP as a Biomarker for Drug Associated Stunting of Growth ReveraGen Biopharma Incorporated

Tracy Brooks $5,295 Total expenditures Synthesis and Optimization of antibody: DNAi conjugates targeting the MYC G4 National Cancer Institute

$12,745 Defining prognostic models of future clinical trajectories in Duchenne Muscular Dystrophy Foundation to Eradicate Duchenne

Katie Edwards $29,658 Total expenditures $26,830 A Non-invasive Point-Of-Care Assay for Monitoring Titin Levels in the Urine of DMD Patients Children’s Research Institute $2,828 Bridging pharmacodynamic biomarkers to clinical outcomes in pediatric inflammatory diseases Children’s Research Institute

$304,084 Clinical Utility of Serum Protein Biomarkers in Very Young Duchenne Muscular Dystrophy Boys U.S. Army Medical Research Acquisition Activity $214,156 Bridging Pharmacodynamic Biomarkers to Clinical Outcomes in Pediatric Inflammatory Diseases Children’s Research Institute $512 A biomarker and patient-reported outcomes study in Becker muscular dystrophy patients ReveraGen Biopharma Incorporated

Wesley Kufel $13,500 Total expenditures Impact of a Pharmacist-Driven Collaborative Initiative for Staphylococcus Aureus Bacteremia Management American Society of Health System Pharmacists

Kanneboyina Nagaraju $314,494 Total expenditures $4,714 Virus Induced Genetic Changes in the Pathogenesis of Autoimmune Myositis National Institute of Allergy and Infectious Diseases $23,077 Urine Biomarkers in Juvenile Dermatomyositis Myositis Association $135,896 Effect of Immunomodulatory Treatments on Immune Response After Gene Correction in DMD Parent Project for Muscular Dystrophy Research Inc

$50,126 Role of Innate Immune and Metabolic Pathways in Mediating Muscle Weakness in Myositis Myositis Association $27,165 Db Therapeutics in the area of radiotherapeutic bandage Db Therapeutics Incorporated $17,288 Understanding the Mechanism and Role of Cell Membrane Repair in Miyoshi Myopathy Children’s Research Institute $43,451 Testing and screening potential compounds for efficacy in a mouse model of myositis and the effect of Type 1 Interferon on muscle function and weakness in myositis Cure Juvenile Myositis Foundation $12,777 Immune response to dystrophin after Etiplerson treatment in Duchenne Muscular Dystrophy Children Foundation to Eradicate Duchenne

L. Nathan Tumey $165,977 Total expenditures $114,167 The Identification of Lysosomal Selective Proteolytically Cleavable Linkers Takeda agreement # CW2510332 Millennium Pharmaceuticals Incorporated $51,810 Cell-specific blockage of TLR activation: A new strategy for addressing inflammatory disorders National Institute of Allergy and Infectious Diseases

Our Founders Society This donor recognition society recognizes donors of $1,000 or more to any fund account in support of the School of Pharmacy and Pharmaceutical Sciences from the school’s inception to FY2020-21. Its members, as of June 30, 2020, are: Mrs. Alyson J. Archer ’96 ˆ Mr. John M. Archer ˆ Dr. Charles N. Aswad ’53 ˆ Mrs. Joanne Aswad ˆ Care Compass Network Mr. Vincent M. Conklin Mr. Gregory Corsico CVS Health Dr. John Martin Darcy II, MS ’07, MA ’10, PhD ’14 ˆ Dr. G. Clifford & Florence B. Decker Foundation Mr. Robin Eccleston ˆ in honor of Delaney Louise Eccleston Dr. Katie Edwards + ˆ Ms. Katharine F. Ellis + ˆ Fidelity Charitable • Dr. Arnold Jay Levine ’61, SD ’97 Foundation to Eradicate Duchenne Ms. Heidi Garwood Dr. Stuart Horowitz ’79 Innovation Associates, Inc. Dr. RoseAnn L. Jankowski Dr. Timothy C. Jankowski Mrs. Naima Kradjian ˆ Lee and Yum Foundation Trust • Dr. Bai O. Lee Ms. Laura McDuffee ’89 + ˆ Mr. James McDuffee ˆ Dr. Christopher Meredith ˆ Mrs. Lisa Meredith

+ Faculty/Staff/Retiree ^ Binghamton Fund donor

Dr. Gloria E. Meredith + ˆ Dr. Kanneboyina Nagaraju + ˆ The Newman Family Foundation, Inc. ˆ • Mr. Mark S. Newman ˆ • Mrs. Sharon M. Newman ˆ Novartis Ms. Karen Reid + ˆ Dr. Angela C. Riley + ˆ Dr. Barry L. Roberts Schorr Family Foundation • Ms. Jennifer Brink Schorr, MBA ’81 + • Dr. Lawrence J. Schorr ’75, MA ’77, LLD ’09 Schwab Charitable • Mrs. Elisabeth Menner Brandt ’66 Dr. Cory Spencer Dr. Sara Asif Spencer + SUNY Impact Foundation Mr. Frank S. Vellucci ’94 ˆ

School of Pharmacy and Pharmaceutical Sciences PO Box 6000 Binghamton, NY 13902-6000 96 Corliss Ave. Johnson CIty, N.Y. 13790 binghamton.edu/pharmacy-and-pharmaceutical-sciences

20-243